Characterization of Drug Interactions with Serum Proteins by Using High-Performance Affinity Chromatography

Author(s): David S. Hage, Jeanethe Anguizola, Omar Barnaby, Abby Jackson, Michelle J. Yoo, Efthimia Papastavros, Erika Pfaunmiller, Matt Sobansky, Zenghan Tong

Journal Name: Current Drug Metabolism

Volume 12 , Issue 4 , 2011


Become EABM
Become Reviewer
Call for Editor

Abstract:

The binding of drugs with serum proteins can affect the activity, distribution, rate of excretion, and toxicity of pharmaceutical agents in the body. One tool that can be used to quickly analyze and characterize these interactions is high-performance affinity chromatography (HPAC). This review shows how HPAC can be used to study drug-protein binding and describes the various applications of this approach when examining drug interactions with serum proteins. Methods for determining binding constants, characterizing binding sites, examining drug-drug interactions, and studying drug-protein dissociation rates will be discussed. Applications that illustrate the use of HPAC with serum binding agents such as human serum albumin, α1-acid glycoprotein, and lipoproteins will be presented. Recent developments will also be examined, such as new methods for immobilizing serum proteins in HPAC columns, the utilization of HPAC as a tool in personalized medicine, and HPAC methods for the high-throughput screening and characterization of drug-protein binding.

Keywords: α1-acid glycoprotein, drug-protein binding, high-performance affinity chromatography, high-throughput screening, human serum albumin, lipoproteins, personalized medicine, toxicity, HPAC, ADME

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 12
ISSUE: 4
Year: 2011
Page: [313 - 328]
Pages: 16
DOI: 10.2174/138920011795202938
Price: $65

Article Metrics

PDF: 14